UNITAID and TB Alliance call for more action against childhood tuberculosis
To develop a correctly-dosed child-friendly first-line TB treatment that is expected to be available within three years
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Bureau of Indian Standards recognises SCHOTT’s expertise in pharmaceutical glass manufacturing
Decision rewards company’s strong commitment to international Good Manufacturing Practice standard
Malaysia-based Bio-XCell and Agila Biotech (Malaysia) sign $34.4 million deal
To set up customised biotech facility located in the Bio-XCell ecosystem in Nusajaya, Johor, Malaysia
Stem cells produce compact, regenerated bone in mandible transplants
Study shows that regenerated bone is also hard, rather than the spongy kind normally found in the jaw
Utkarsh Palnitkar joins KPMG
He joins as Partner and National Head of Transactions & Restructuring practice and for the Life sciences practice
WHO & Global Fund to Fight AIDS, Tuberculosis and Malaria seek more international funding
Highlights a funding gap of at least $1.6 billion a year
HKCP organises one-day national seminar on ‘Advances in Instrumentation and Application’
Poster competition’ was held in association with Shimadzu Analytical (India)
Taming MDR TB
The battle against MDR TB calls for concerted action from multiple stakeholders. Viveka Roychowdhury asks multiple stakeholders…
’It only takes 2.1 treatment errors to convert a TB patient into an MDR patient’
Dr Zarir F Udwadia, Consultant Chest Physician feels irresponsible prescription patterns and rampant self-medication are the main…
’For the first time in 50 years, there is hope’
Leena Menghaney, Manager (India), Access Campaign, Medecins Sans Frontieres feels that the Health Ministry and Drug Regulatory…
‘Engaging the private sector is important to prevent TB spread’
Dr Evan Lee, Vice President of Global Health Programs, Eli Lilly talks to Viveka Roychowdhury about the role of private players to…
‘It is important to listen to, respect the patient’s voice’
Blessina Kumar, Delhi-based health activist and public health consultant spoke to Viveka Roychowdhury on the crucial need to make…
‘Media and the TB control sector time to build a relationship’
Bharathi Ghanashyam, from Journalists against TB outlines the reasons why TB ranks very low with the media
‘Preventing drug-resistant TB in India’
Madhukar Pai, Professor, McGill University, Montreal, Canada says a trans-formational change in the relationship between the…
’Pharmacists: an untapped potential in TB care and control’
Manjiri Gharat, Vice-President and Chairperson, Indian Pharmaceutical Association-Community Pharmacy Division (IPA CPD) speaks to…
‘Response to TB in India needs bold policies’
Dr Suvanand Sahu, Team Leader for TB-REACH, Stop TB Partnership presents seven points important to address TB and prevent further…
TB diagnosis in India Challenges and opportunities
Dr Sanjay Sarin, Regional Director, Global Health (Central & South Asia Pacific), BD elaborates on the challenges and…
Epidemiology of TB in India
Dr Giridhar R Babu, Associate Professor, Public Health Foundation of India discusses the imminent need for improved diagnostics…
Glenmark confirms patent challenge for its generic version of FINACEA
Is indicated for the topical treatment of inflammatory papules and pustules of mild to moderate rosacea